Israel’s Teva Pharmaceutical has received marketing authorisation from the European Commission (EC) for Ajovy (fremanezumab), an injection intended to provide relief from migraines.
Mylan and Fujifilm Kyowa Kirin Biologics announced the European Commission (EC) has granted marketing authorization for Hulio, a biosimilar to AbbVie's Humira (adalimumab), for all indications.